Cyclosporine A in hospitalized COVID-19 pneumonia patients to prevent the development of interstitial lung disease: a pilot randomized clinical trial.

Autor: Cobo-Ibáñez T; Department of Rheumatology, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain. mtcoboiba@yahoo.es.; Fundación para la Investigación e Innovación Biomédica del Hospital Universitario Infanta Sofía y Hospital Universitario del Henares (FIIB HUIS HHEN), 28702, Madrid, Spain. mtcoboiba@yahoo.es., Mora Ortega G; Department of Pneumology, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain., Sánchez-Piedra C; Instituto de Salud Carlos III, 28029, Madrid, Spain., Serralta-San Martín G; Department of Internal Medicine, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain., Thuissard-Vasallo IJ; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, 28670, Madrid, Spain., Lores Gutiérrez V; Department of Pneumology, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain., Soler Rangel L; Department of Internal Medicine, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain., García Yubero C; Deparment of Pharmacy, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Esteban-Vázquez A; Department of Rheumatology, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain., López-Aspiroz E; Deparment of Pharmacy, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Andreu Vázquez C; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, 28670, Madrid, Spain., Toboso I; Deparment of Immunology, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Martínez Alonso de Armiño BM; Department of Emergency, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Olivares Alviso RA; Department of Emergency, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Calderón Nieto R; Department of Emergency, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Yañez C; Department of Emergency, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Zakhour González MA; Department of Emergency, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Sainz Sánchez T; Department of Pneumology, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain., Arroyo de la Torre S; Department of Pneumology, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain., Del Amo Del Arco N; Central Laboratory, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Gómez-Cerezo JF; Department of Internal Medicine, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain., Ramírez Prieto T; Department of Pneumology, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain., Martínez Hernández A; Deparment of Pharmacy, Hospital Universitario Infanta Sofía, 28702, Madrid, Spain., Muñoz-Fernández S; Department of Rheumatology, Hospital Universitario Infanta Sofía, Universidad Europea de Madrid, 28702, Madrid, Spain.

Publikováno v: Scientific reports [Sci Rep] 2024 Feb 15; Vol. 14 (1), pp. 3789. Date of Electronic Publication: 2024 Feb 15.

Individualized Protease Inhibitor Monotherapy: The Role of Pharmacokinetics and Pharmacogenetics in an Aged and Heavily Treated HIV-Infected Patient.

Autor: López Aspiroz E; Pharmacy Service, University Hospital Infanta Sofía, San Sebastián de Los Reyes, Paseo de Europa 34, 28709, Madrid, Spain., Cabrera Figueroa SE; Pharmacy Department, Pharmacy Faculty, University of Concepcion, Víctor Lamas 1290, 4070386, Concepción, Chile. scabrera@ssconcepcion.cl.; Pharmacy Service, Regional Clinical Dr. Guillermo Grant Benavente Hospital, San Martín 1436, Concepción, Chile. scabrera@ssconcepcion.cl., Valverde Merino MP; Pharmacy Service, University Hospital of Salamanca, Paseo de San Vicente 139, 37007, Salamanca, Spain., Carracedo Álvarez Á; Galician Public Foundation of Genomic Medicine, Health Research Institute of Santiago (IDIS), 15706, Santiago de Compostela, Spain.; Genomic Medicine Group, CIBERER, CIMUS (Centre for Research in Molecular Medicine and Chronic Diseases), University of Santiago de Compostela, 15706, Santiago de Compostela, Spain.

Publikováno v: Clinical drug investigation [Clin Drug Investig] 2019 Nov; Vol. 39 (11), pp. 1125-1131.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Population pharmacokinetic/pharmacogenetic model of lopinavir/ritonavir in HIV-infected patients.

Autor: López Aspiroz E; Pharmacy Service, University Hospital of Salamanca, Paseo de San Vicente 58, 37007 Salamanca, Spain., Santos Buelga D; Department of Pharmacy & Pharmaceutical Technology, Faculty of Pharmacy, University of Salamanca, Salamanca, Spain., Cabrera Figueroa SE; Pharmacy Service, University Hospital of Salamanca, Paseo de San Vicente 58, 37007 Salamanca, Spain.; Instituto de Farmacia, Facultad de Ciencias, Universidad Austral de Chile, Valdivia, Chile., Valverde Merino MP; Pharmacy Service, University Hospital of Salamanca, Paseo de San Vicente 58, 37007 Salamanca, Spain., Cordero Sánchez M; Infectious Disease Service, University Hospital of Salamanca, Salamanca, Spain., Domínguez-Gil Hurlé A; Pharmacy Service, University Hospital of Salamanca, Paseo de San Vicente 58, 37007 Salamanca, Spain.; Department of Pharmacy & Pharmaceutical Technology, Faculty of Pharmacy, University of Salamanca, Salamanca, Spain., Carracedo Á; Grupo de Medicina Xenómica. Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), Universidad de Santiago de Compostela, Spain.; Fundación Pública Galega de Medicina Xenómica, Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS), SERGAS (Servicio Galega de Saude), Santiago de Compostela, Spain.; Center of Excellence in Genomic Medicine Research, King Abdulaziz University, Jeddah, Saudi Arabia., García Sánchez MJ; Department of Pharmacy & Pharmaceutical Technology, Faculty of Pharmacy, University of Salamanca, Salamanca, Spain.

Publikováno v: Personalized medicine [Per Med] 2014 Sep; Vol. 11 (7), pp. 693-704.

Population pharmacokinetics of lopinavir/ritonavir (Kaletra) in HIV-infected patients.

Autor: López Aspiroz E; Pharmacy Service, University Hospital of Salamanca, Salamanca, Spain., Santos Buelga D, Cabrera Figueroa S, López Galera RM, Ribera Pascuet E, Domínguez-Gil Hurlé A, García Sánchez MJ

Publikováno v: Therapeutic drug monitoring [Ther Drug Monit] 2011 Oct; Vol. 33 (5), pp. 573-82.